[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Bio Stocks™ [@BioStocks](/creator/twitter/BioStocks) on x 68.6K followers Created: 2025-07-23 12:11:04 UTC $ARWR should Sarepta fail to make either the $100M or $200M near-term payment associated with enrollment of ARO-DM1 cohorts, or fail to make any development or commercial milestone payment, Arrowhead would have the right to terminate the agreement. $SRPT XXXXX engagements  **Related Topics** [100m](/topic/100m) [$srpt](/topic/$srpt) [arrowhead](/topic/arrowhead) [$200m](/topic/$200m) [$100m](/topic/$100m) [stocks](/topic/stocks) [$arwr](/topic/$arwr) [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc) [Post Link](https://x.com/BioStocks/status/1947992860705558911)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Bio Stocks™ @BioStocks on x 68.6K followers
Created: 2025-07-23 12:11:04 UTC
$ARWR should Sarepta fail to make either the $100M or $200M near-term payment associated with enrollment of ARO-DM1 cohorts, or fail to make any development or commercial milestone payment, Arrowhead would have the right to terminate the agreement. $SRPT
XXXXX engagements
Related Topics 100m $srpt arrowhead $200m $100m stocks $arwr sarepta therapeutics inc
/post/tweet::1947992860705558911